Skip to main content
TipRanks
Go Ultimate75% OFF

Randall Schatzman Insider Profile

4 Followers

Randall Schatzman, CEO, Director at Bolt Biotherapeutics, holds 1.50K shares in Bolt Biotherapeutics (Ticker: BOLT), holds 111.58K shares in Alder Biopharmaceuticals (Ticker: ALDR). Most recently, Randall Schatzman Bought ― shares of Bolt Biotherapeutics on Feb 09, 2021 for an estimated value of $30.00K.

Randall Schatzman's Trading History

BOLT
Bolt Biotherapeutics
Feb 09, 2021CEO, DirectorInformative Buy30.00K$9.12K
ALDR
Alder Biopharmaceuticals
Jan 31, 2017―Uninformative Buy8.16K$2.11M

You May Also Like

Randall Schatzman insider profile FAQ

What is the percentage of profitable transactions made by Randall Schatzman?
The percentage of profitable transactions made by Randall Schatzman is 50%.
What is the average return per transaction made by Randall Schatzman?
The average return per transaction made by Randall Schatzman is -29.40%.
What stocks does Randall Schatzman hold?
Randall Schatzman holds: BOLT, ALDR stocks.
What was Randall Schatzman’s latest transaction?
Randall Schatzman’s latest transaction was an Informative Buy of $30.00K.
What was Randall Schatzman's most profitable transaction?
Randall Schatzman’s most profitable transaction was an Informative Sell of ALDR stock on May 28, 2015. The return on the trade was 31.20%.
What is Randall Schatzman's role in Bolt Biotherapeutics?
Randall Schatzman's role in Bolt Biotherapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.